Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sarah Rauch

1PUBLICATIONS

13CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Apr 28, 2025

Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth.

Hilary A Kenny, Carman Ka Man Ip, Lucy Kelliher

Pageof 1

Frequent Collaborators

1 joint publications

Hilary A Kenny

1 joint publications

Carman Ka Man Ip

1 joint publications

Lucy Kelliher

1 joint publications

Tejas Samantaray

1 joint publications

Kasjusz Kordylewicz

1 joint publications

Rachael Hoffmann

1 joint publications

Beatrice Malacrida

1 joint publications

Sophie L P Skingsley

1 joint publications

Frances R Balkwill

1 joint publications

Chiara Battistini

Frequent Collaborators

1 joint publications

Hilary A Kenny

1 joint publications

Carman Ka Man Ip

1 joint publications

Lucy Kelliher

1 joint publications

Tejas Samantaray

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos